SCOPE: Epidemiological studies provide evidence that consumption of cruciferous vegetables, like broccoli, can reduce the risk of cancer development. Sulforaphane (SFN) is a phytochemical derived from cruciferous vegetables that induces anti-proliferative and pro-apoptotic responses in prostate cancer cells, but not in normal prostate cells. The mechanisms responsible for this cancer-specific cytotoxicity remain unclear. METHODS AND RESULTS: We utilized RNA sequencing and determined the transcriptomes of normal prostate epithelial cells, androgen-dependent prostate cancer cells, and androgen-independent prostate cancer cells treated with SFN. SFN treatment dynamically altered gene expression and resulted in distinct transcriptome profiles depending on prostate cell line. SFN also down-regulated the expression of genes that were up-regulated in prostate cancer cells. Network analysis of genes altered by SFN treatment revealed that the transcription factor Specificity protein 1 (Sp1) was present in an average of 90.5% of networks. Sp1 protein was significantly decreased by SFN treatment in prostate cancer cells and Sp1 may be an important mediator of SFN-induced changes in expression. CONCLUSION: Overall, the data show that SFN alters gene expression differentially in normal and cancer cells with key targets in chemopreventive processes, making it a promising dietary anti-cancer agent.
SCOPE: Epidemiological studies provide evidence that consumption of cruciferous vegetables, like broccoli, can reduce the risk of cancer development. Sulforaphane (SFN) is a phytochemical derived from cruciferous vegetables that induces anti-proliferative and pro-apoptotic responses in prostate cancer cells, but not in normal prostate cells. The mechanisms responsible for this cancer-specific cytotoxicity remain unclear. METHODS AND RESULTS: We utilized RNA sequencing and determined the transcriptomes of normal prostate epithelial cells, androgen-dependent prostate cancer cells, and androgen-independent prostate cancer cells treated with SFN. SFN treatment dynamically altered gene expression and resulted in distinct transcriptome profiles depending on prostate cell line. SFN also down-regulated the expression of genes that were up-regulated in prostate cancer cells. Network analysis of genes altered by SFN treatment revealed that the transcription factor Specificity protein 1 (Sp1) was present in an average of 90.5% of networks. Sp1 protein was significantly decreased by SFN treatment in prostate cancer cells and Sp1 may be an important mediator of SFN-induced changes in expression. CONCLUSION: Overall, the data show that SFN alters gene expression differentially in normal and cancer cells with key targets in chemopreventive processes, making it a promising dietary anti-cancer agent.
Authors: Shivendra V Singh; Renaud Warin; Dong Xiao; Anna A Powolny; Silvia D Stan; Julie A Arlotti; Yan Zeng; Eun-Ryeong Hahm; Stanley W Marynowski; Ajay Bommareddy; Dhimant Desai; Shantu Amin; Robert A Parise; Jan H Beumer; William H Chambers Journal: Cancer Res Date: 2009-02-17 Impact factor: 12.701
Authors: Rong Hu; Vidya Hebbar; Bok-Ryang Kim; Chi Chen; Bozena Winnik; Brian Buckley; Patricia Soteropoulos; Peter Tolias; Ronald P Hart; A-N Tony Kong Journal: J Pharmacol Exp Ther Date: 2004-02-26 Impact factor: 4.030
Authors: Roble G Bedolla; Jingjing Gong; Thomas J Prihoda; I-Tien Yeh; Ian M Thompson; Rita Ghosh; Addanki P Kumar Journal: PLoS One Date: 2012-09-13 Impact factor: 3.240
Authors: Maria H Traka; Caroline A Spinks; Joanne F Doleman; Antonietta Melchini; Richard Y Ball; Robert D Mills; Richard F Mithen Journal: Mol Cancer Date: 2010-07-13 Impact factor: 27.401
Authors: Zhenzhen Zhang; Mark Garzotto; Edward W Davis; Motomi Mori; Wesley A Stoller; Paige E Farris; Carmen P Wong; Laura M Beaver; George V Thomas; David E Williams; Roderick H Dashwood; David A Hendrix; Emily Ho; Jackilen Shannon Journal: Nutr Cancer Date: 2019-06-01 Impact factor: 2.900
Authors: Laura M Beaver; Rachael Kuintzle; Alex Buchanan; Michelle W Wiley; Sarah T Glasser; Carmen P Wong; Gavin S Johnson; Jeff H Chang; Christiane V Löhr; David E Williams; Roderick H Dashwood; David A Hendrix; Emily Ho Journal: J Nutr Biochem Date: 2017-01-12 Impact factor: 6.048
Authors: Gavin S Johnson; Jia Li; Laura M Beaver; W Mohaiza Dashwood; Deqiang Sun; Praveen Rajendran; David E Williams; Emily Ho; Roderick H Dashwood Journal: Mol Nutr Food Res Date: 2017-01-03 Impact factor: 5.914
Authors: Gregory W Watson; Samanthi Wickramasekara; Claudia S Maier; David E Williams; Roderick H Dashwood; Emily Ho Journal: EuPA Open Proteom Date: 2015-08-10